With the unprecedented results seen with novel therapies, what is needed to overcome the poor prognosis of high-risk MM? episode artwork

EPISODE · Jun 30, 2021 · 5 MIN

With the unprecedented results seen with novel therapies, what is needed to overcome the poor prognosis of high-risk MM?

from Multiple Myeloma Hub

During the EHA2021 Virtual Congress, the Multiple Myeloma Hub spoke with Pieter Sonneveld, Erasmus MC, Rotterdam, NL. We asked, With the unprecedented results seen with novel therapies, what is needed to overcome the poor prognosis of high-risk multiple myeloma (MM)?In this podcast, Sonneveld discusses trial results presented during EHA2021 on the efficacy of novel treatments for patients with high-risk MM, a patient group associated with poor outcomes and shorter remission rates. He believes that identifying high-risk patients and selecting them for more intensive targeted maintenance treatment could be crucial in preventing relapse. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published Jun 30, 2021

Embed this episode

NOW PLAYING

With the unprecedented results seen with novel therapies, what is needed to overcome the poor prognosis of high-risk MM?

0:00 5:09

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Multiple Myeloma Hub?

This episode is 5 minutes long.

When was this Multiple Myeloma Hub episode published?

This episode was published on June 30, 2021.

Can I download this Multiple Myeloma Hub episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!